Trial intelligence / Profile preview

Oseltamivir in laboratory-confirmed influenza

2006-006263-23Phase 4Terminated

Sponsor
Roche
Start
Jan 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of oseltamivir in influenza, Influenza A infection and influenza B, sponsored by Roche. Primary endpoints: Time to return to normal health status and Time to return to normal levels of activity. Started Jan 2012; status: terminated.

02

Drugs

oseltamivir
03

Conditions

influenzaInfluenza A infectioninfluenza B

Beyond the preview

Go deeper on 2006-006263-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006263-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call